197 related articles for article (PubMed ID: 33448318)
1. Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway.
Li N; Wu K; Feng F; Wang L; Zhou X; Wang W
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33448318
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
3. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway.
Wang J; Fang C; Wang S; Fang F; Chu X; Liu N; Lu C; Wang S; Li W
J Tradit Chin Med; 2020 Apr; 40(2):236-244. PubMed ID: 32242389
[TBL] [Abstract][Full Text] [Related]
4. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway.
Feng F; Li N; Cheng P; Zhang H; Wang H; Wang Y; Wang W
Biomed Pharmacother; 2020 Jan; 121():109586. PubMed ID: 31706104
[TBL] [Abstract][Full Text] [Related]
6. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
Du N; Xu Z; Gao M; Liu P; Sun B; Cao X
Drug Des Devel Ther; 2018; 12():3517-3524. PubMed ID: 30425453
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid prevents high glucose‑induced expression of extracellular matrix protein in cardiac fibroblasts by inhibiting the TGF‑β1/Smad signaling pathway.
Jiang L; Chen FX; Zang ST; Yang QF
Mol Med Rep; 2017 Nov; 16(5):6320-6325. PubMed ID: 28849070
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
9. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling.
Sun Y; Liu B; Xie J; Jiang X; Xiao B; Hu X; Xiang J
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35322863
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
11. Emodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contact.
Yang T; Wang J; Pang Y; Dang X; Ren H; Liu Y; Chen M; Shang D
Mol Med Rep; 2016 Nov; 14(5):4643-4649. PubMed ID: 27748907
[TBL] [Abstract][Full Text] [Related]
12. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
14. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
15. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
[TBL] [Abstract][Full Text] [Related]
16. The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation.
Feng F; Cheng P; Zhang H; Li N; Qi Y; Wang H; Wang Y; Wang W
Drug Des Devel Ther; 2019; 13():4275-4290. PubMed ID: 31908414
[TBL] [Abstract][Full Text] [Related]
17. Anti‑fibrotic effects and the mechanism of action of miR‑29c in silicosis.
Huang L; Zhang Y; Yang J; Li J; Wu J; Wang F; Lan Y; Zhang Q
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33649785
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.
Chen K; Chen W; Liu SL; Wu TS; Yu KF; Qi J; Wang Y; Yao H; Huang XY; Han Y; Hou P
Mol Med Rep; 2018 Jun; 17(6):7652-7660. PubMed ID: 29620209
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
Liu Q; Mao H; Nie J; Chen W; Yang Q; Dong X; Yu X
Perit Dial Int; 2008 Jun; 28 Suppl 3():S88-95. PubMed ID: 18552272
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
